Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
5m agoZacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
5m agoMEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
5m agoVS Media Enters the AI Smart Living Sector to Explore New Growth Opportunities
32m agoGalderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
32m agoSurface Transforms plc – in Administration, Sale of Business and Assets
Racura Oncology Ltd logo

Racura Oncology Ltd

About

2.48AUD+0.03 +1.22%
Closed • Updated at 17:07 GMT+00:00
Market Cap$333.22M
Volume162.5K
Beta-0.28
RSI44.41
Health TechnologyPharmaceuticals: Major

Racura Oncology Ltd — investor relations, events, news, and company updates on 6ix.

Latest News

May 15 2026
Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial
May 15 2026
CPACS Trial Cleared to Escalate to Next RC220 Dose Level
May 6 2026
(E,E)-bisantrene Discovered to Function via Silencing of c-MYC Expression
Apr 30 2026
March 2026 Quarterly Activity Report and Appendix 4C
Apr 22 2026
Racura presents MYC silencing data at AACR 2026

Community Chat

Ask AI

6ix6ixAIEvents